SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-11-000690
Filing Date
2011-08-11
Accepted
2011-08-11 16:08:53
Documents
3
Group Members
DOMINIQUE SEMONMERLIN BIOMED PRIVATE EQUITY ADVISORS, LLCMERLIN NEXUS III, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D ss125494_sc13da.htm SC 13D/A 97500
2 JOINT LETTER ss125494_ex9904.htm EX-99.4 17988
3 PRESS RELEASE ss125494_ex9905.htm EX-99.5 13438
  Complete submission text file 0000947871-11-000690.txt   130364
Mailing Address
Business Address 4222 EMPEROR BLVD SUITE 350 DURHAM NC 27703 919-941-5206
ICAGEN INC (Subject) CIK: 0000902622 (see all company filings)

IRS No.: 561785001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81358 | Film No.: 111027850
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169
Business Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169 646-227-5270
Merlin BioMed Private Equity Advisors, L.L.C. (Filed by) CIK: 0001429303 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A